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Abstract 22 
 23 
Environmental contaminants considered endocrine disruptors have been shown to affect testis 24 
development and function but the mechanisms of action are not clear. We now have analyzed the 25 
effects on the transcriptome in testes of mice exposed to mono-(2-ethylhexyl)-phthalate (9.2; 46.3 26 
or 92.7 mg/kg/d), zearalenone (1.3; 3.9 or 6.6 mg/kg/d), lindane (16.6; 32.2 or 64.4 mg/kg/d), 27 
bisphenol-A (0.16; 16 or 64 mg/kg/d) or 17β-estradiol (0.006; 0.012 or 0.048 mg/kg/d). The 28 
compounds were orally administered in the drinking water during distinct developmental periods: 29 
A) mothers were exposed only during the two weeks before mating; B) the exposure was 30 
continued during pregnancy until birth or C) exposure was continued for a further four weeks 31 
after birth. Testes were studied at four weeks of age. Mono-(2-ethylhexyl)-phthalate and 32 
zearalenone, both produced specific alterations of gene signatures. Interestingly, this was 33 
irrespective of the concentration of the toxicant or the developmental period during which 34 
exposure occurred. 35 
 36 
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1. Introduction 48 
 49 
There is significant documentation on the adverse effects of environmental pollutants on 50 
reproductive health [1-3]. Environmental toxicants that act as agonists or antagonists of natural 51 
hormones, generically considered as endocrine disruptors (EDs), can affect the development of 52 
the reproductive system and associated organs [4, 5]. There is some controversy as to the effects 53 
and mechanisms by which EDs act [6, 7], although the most accepted hypothesis holds that EDs 54 
interfere with steroid hormone action through disruption of steroid biosynthesis, the hormone 55 
balance, signaling pathways of downstream consequences. There is currently significant concern 56 
regarding the increase in male and female hormone-related disorders detected in epidemiological 57 
studies. In mammals, the male reproductive organs have been clearly identified as a target for the 58 
deleterious action of many environmental toxicants, and the Testicular Dysgenesis Syndrome 59 
(TDS) could be a consequence of developmental exposure to such compounds [8, 9]. TDS groups 60 
four clinical and etiologically related traits: hypospadias, cryptorchidism, low sperm counts and 61 
testicular tumors [10]. These dysfunctions could originate through changes in the 62 
microenvironment that affect different target cells during embryonic differentiation [11]. 63 
Nevertheless, the molecular mechanisms by which toxicants or potential EDs alter 64 
spermatogenesis and testicular function are yet to be fully established. Indeed, their effects cannot 65 
be simply explained by direct interactions with hormone pathways [12], and interference with 66 
gene expression regulation could occur at diverse levels during development, either as a direct or 67 
indirect consequence of exposure to these toxicants. The nature of the compounds, the dose and 68 
extent of exposure, as well as the developmental period at which exposure occurs are also factors 69 
that should be taken into account when considering the mechanisms causing the adverse effects 70 
on testicular development and function. 71 
There is evidence that the origin of the adverse effects lies in fetal exposure [13]. 72 
Potential effects of endocrine disruptors via placental transport during pregnancy and via milk 73 
during lactation are well documented. Transplacental absorption and fetal detection of different 74 
environmental estrogenic compounds has been reported in experimental animals [14-16] and in 75 
humans [17, 18]. Similarly, persistence in breast milk was detected in different populations [19-76 
21]. Nevertheless, the mechanisms underlying the influence of the different xeno-compounds are 77 
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not well established, especially since daily exposure usually involves contact with a mixture of 78 
contaminants. 79 
Over 150 different contaminants have been reported in individuals in the US and some, 80 
such as phthalates, can be found in nearly 100% of the population [22]. In humans, basic studies 81 
associating chemical exposure and testis development disorders are very difficult to carry out 82 
[13]. Indeed, most of the biomarkers that could serve as endpoints, such as semen quality or 83 
hormone levels, cannot be considered as direct or adequate evaluation of toxicological exposure 84 
[23]. 85 
To date, studies into the environmental induction of changes in gene expression and 86 
regulation as part of disease etiology have mainly focused on specific genes or on the relevant 87 
genetic pathways related to particular diseases, including reproductive dysfunction [24]. 88 
However, most emphasis has been placed on altered gene expression mediated by estrogen 89 
receptors [25]. Some EDs can also act as anti-androgens [26, 27] producing specific alterations in 90 
gene expression [28]. Considering that developmental exposure to EDs interferes with gene 91 
expression in the testis, a comparison was performed here to evaluate whether specific EDs, with 92 
potential different molecular mechanisms of action, induce specific signatures at a global level of 93 
gene expression. In addition, we studied whether these compounds act in similar pathways of 94 
estrogen signaling and render similar signatures of gene expression, as well as whether specific 95 
patterns of gene modulation can be associated to developmental windows and/or doses of 96 
exposure and to cytological/histological changes in the seminiferous epithelium.  97 
To address these questions, we used DNA microarrays that represent the global mouse 98 
transcriptome (31,769 printed 70-mer DNA probes corresponding to 24,878 expressed or 99 
predicted genes) to analyze the effects on gene expression of five environmental pollutants 100 
considered as EDs. Bisphenol-A (BPA) is one of the most intensely produced plasticizers 101 
worldwide that can leach into food and beverages [29]. BPA has been detected in blood samples 102 
and other fluids, and there is still considerable controversy regarding its potential effects [30]. 103 
Lindane (γ-hexachlorocyclohexane, LIN) is one of the oldest synthetic pesticides and despite 104 
being considered a persistent toxicant that adversely affects reproductive functions in animals 105 
[10, 31], it is still in use worldwide. Mono 2-ethylhexyl phthalate (MEHP) is the active 106 
metabolite of di 2-ethylhexyl phthalate (DEHP) and is widely used as plastic flexibilicizer despite 107 
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its reported estrogenic/antiandrogenic effect [11, 32, 33]. Zearalenone (ZEA) is a toxic substance 108 
considered a phytoestrogen that is produced by Fusarium spp., a contaminant of grain, and is 109 
thought to cause male germ cell toxicity [34]. Finally, we assessed the effects of 17-β-estradiol 110 
(E2) as a natural estrogen. 111 
The effects of each of these compounds on the transcriptome were compared after 112 
exposure during different developmental periods, and at different concentrations for each period. 113 
The objective was to evaluate the level of global gene expression modification in the testes of 114 
mice exposed to EDs and the signature of gene expression they provoked considering three 115 
factors: compound specificity, the developmental window and the dosage of exposure. 116 
Morphological effects on testicular development and spermatogenesis were also evaluated after 117 
the various experimental conditions. The parameters studied were: body and testis weight, the 118 
numbers of apoptotic cells in the testis, the percentage of tubule sections showing abnormalities 119 
such as missing generations of germ cells or abnormal cell associations, and the number of 120 
diploid spermatids as a measure of problems occurring at meiotic divisions. 121 
 122 
2. Materials and methods 123 
 124 
2.1. Ethics Statement 125 
 All animal care and the procedures for sacrificing the animals were in accordance with the 126 
regulations laid down by the CSIC Bioethics Committee and the relevant European Commission 127 
(EC) guidelines (directive 86/609/EEC). The present study was approved by the CSIC Bioethics 128 
Committee (ID number: CB/CIB-PI071007-2007). 129 
 130 
2.2. Animal Exposure 131 
 CD-1 mice were supplied by our own animal facility, the CIB-CSIC bioterium. Breeding 132 
and production of the mice were carried out under specific pathogen-free (SPF), controlled 133 
temperature (22±1ºC) and regulated humidity (50-55%) conditions; periods of light/dark 12h and 134 
diet available at libitum. 135 
CD-1 mice were exposed to different doses of EDs in vivo following a defined regimen, 136 
detailed in Figure 1. In all cases, females were mated with unexposed males. The day when the 137 
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vaginal plug was detected was recorded as day 0. The age-range of the parental mice used in this 138 
study was 2-3 months. At least, three adult females were exposed to each dose and ED during 139 
developmental exposure A, B and C. The male offspring were sacrificed at four weeks of age to 140 
obtain their testes for the different analysis. At least, three males, offspring from different 141 
mothers, including those from exposure C which were also exposed during four weeks after birth 142 
were used for RNA purification. For the histological and morphological analysis we proceeded 143 
using the same protocol of exposure and number of animals. The number of animals tested for 144 
histological analysis is explicitly indicated in the figures S2-S11. The control groups were 145 
comprised of the same number of animals and the exposure route for the appropriate vehicle was 146 
similar to that for mice that received an ED. 147 
 To emulate the regular intake of the environmental toxicants studied and to approximate 148 
the route of administration to whole body exposure, the compounds were administered orally in 149 
the drinking water at different dosages during different periods of development to reach the doses 150 
indicated in Table 1. As a result, 45 different experimental conditions were compared in this 151 
study. The estimated intakes were calculated on the basis of average of drinking and body weight 152 
as recorded in pilot experiments and in agreement with the data in the literature referred to these 153 
parameters. In utero and neonatal exposure was assumed to occur via placental transport and via 154 
milk, respectively. Ethanol was used as the vehicle for E2, BPA and ZEA, and DMSO for MEHP 155 
and LIN. Comparative control testes for microarray hybridizations were obtained from animals 156 
exposed to the vehicle alone, following the same exposure regimens as for EDs, detailed in 157 
Figure 1: ethanol at estimated intake of 0.060 g/kg/day and DMSO at 0.029 g/kg/day. The 158 
NOAEL (No-observed-adverse-effect-level) has been established at 2.4 g/kg/day for ethanol 159 
(OECD-SIDS, www.jetoc.or.jp/HP_SIDS/pdffiles/64-17-5.pdf) and at 2.5 g/kg/day for DMSO 160 
(http://www.epa.gov/oppt/chemrtk/pubs/summaries/dimthslf/c14721rr.pdf). All control mice 161 
were exposed to doses of vehicle equivalents to those for each ED. 162 
 163 
2.3. Histological Parameters Studied 164 
 At least, 3 different mice were analyzed after every experimental condition. From each 165 
animal, body weight and testis weight were registered and relative testis weight were calculated 166 
(absolute testis weight proportioned to the body weight). Epithelial abnormalities of the 167 
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seminiferous tubules, namely vacuolisation, missing germ cell generations or abnormal germ cell 168 
associations were observed in PAS-hematoxylin stained sections and the numbers of tubules 169 
showing these abnormalities were counted and expressed per 100 tubule sections. In the same 170 
slides, the diameters of 25 cross sections of seminiferous tubules were measured per animal, and 171 
the average tubule diameter was calculated. To assess problems at the second meiotic division, 172 
tubules containing diploid spermatids were counted and the percentage of the tubules containing 173 
diploid spermatids was determined. The number of TUNEL positive cells was counted in all 174 
testes and calculated as numbers per 100 tubule cross sections. At least 100 tubules per animal 175 
were studied (all histological parameters studied are shown in Supplementary figure S12). 176 
Numbers were expressed as means ± SEM and statistical analysis was performed using the 177 
Univariate Analysis of Variance. 178 
 179 
2.4. Apoptosis detection by way of Terminal deoxynucleotidyl transferase-mediated deoxyuridine 180 
5-triphosphate-biotin nick end labeling (TUNEL) 181 
 Five µm Bouins fixed, paraffin embedded testis sections were incubated for 5 min in 182 
10mM citric buffer (pH6.0) at 98°C and slowly cooled to room temperature (RT). Endogenous 183 
peroxidase was blocked with 3% H2O2 in water for 5 min. Sections were washed three times with 184 
PBS before a 60 min incubation in TUNEL mix at 37°C. TUNEL mix consisted of 0.3 U/mL calf 185 
thymus terminal deoxynucleotidyl transferase (GE Healthcare Bio-Sciences AB, Uppsala, 186 
Sweden), 6.66 mM/mL biotin dUTP (Roche Applied Science, Penzberg, Germany) in terminal 187 
transferase buffer (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). The TUNEL reaction 188 
was stopped by incubation in 300mM NaCl, 30mM Sodium citrate in water for 15 min at RT. 189 
After washing in PBS, sections were blocked with 2% BSA (Sigma-Aldrich, St. Gallen, 190 
Switzerland) in PBS at RT for 10 min. Sections were treated for 30 min at 37°C in a moist 191 
chamber with a 1:20 dilution of ExtrAvidin peroxidase antibody. After three washes in PBS, 192 
detection was performed with DAB+ (Dako, Glostrup, Denmark). Sections were counterstained 193 
with Mayer’s hematoxylin, dehydrated and mounted with Pertex (Cellpath, Newtown, UK). No 194 
statistically significant differences in the evaluated parameters were seen between samples from 195 
animals exposed only to the vehicle of the compounds used as controls versus unexposed, i.e., 196 
EtOH or DMSO versus H2O. 197 
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 198 
2.5. RNA preparation 199 
 Total RNA from the testes was extracted using TRIzol (Invitrogen, part of Life 200 
Technologies, Carlsbad, CA, USA) according to the manufacturer’s instructions and the RNA 201 
was then purified with MegaClear (Ambion, brand of Life Technologies, Carlsbad, CA, USA). 202 
To minimize the inter-individual variability and considering the broad number of variables (45) 203 
in the global analysis, we used pools prepared from RNA samples from at least three individual 204 
testes (5 µg total RNAs each) exposed to every experimental condition: compound, dose and 205 
developmental stage and its respective controls. RNA quality was checked using the Experion 206 
automated electrophoresis system (Bio-Rad Laboratories, Hercules, CA, USA). Samples with an 207 
rRNA ratio (28S/18S) higher than 1.4 were used for the experiments. Total RNA from samples 208 
exposed to EDs and vehicles (DMSO or ETOH) (controls) (1.5 µg for each pool) was amplified 209 
using the Amino Allyl MessageAmp aRNA kit (Ambion, brand of Life Technologies, Carlsbad, 210 
CA, USA) and we obtained 15-60 µg of amino-allyl amplified RNA (aRNA). The mean aRNA 211 
size was approximately 1500 nucleotides when measured in the Experion analyzer. For each 212 
sample, 2.5 µg of aRNA was labeled with one aliquot of Cy3 or Cy5 mono NHS ester (CyDye 213 
Post-labeling Reactive Dye, GE Healthcare Bio-Sciences AB, Uppsala, Sweden) and it was 214 
purified with the Amino Allyl MessageAmp aRNA kit. Cy3 and Cy5 incorporation was measured 215 
using 1 µl of probe in a Nanodrop spectrophotometer (Nanodrop Technologies, brand of Thermo 216 
Fisher Scientific, Waltham, MA, USA). For hybridization, 110-150 pmol of the Cy3 and Cy5 217 
probes were mixed, dried in a speed-vacuum and resuspended in 9 µl RNase-free water. Labeled 218 
aRNA was fragmented by adding 1 µl of 10x fragmentation buffer (Ambion, brand of Life 219 
Technologies, Carlsbad, CA, USA) and incubating for 15 min at 70ºC. The reaction was 220 
terminated by adding 1 µl of the stop solution (Ambion, brand of Life Technologies, Carlsbad 221 
CA, USA). 222 
In order to minimize potential biological variations between individuals as effect of the 223 
compounds, a pool of at least three individual RNA samples was used in each experimental 224 
condition. Sample pooling, by mixing mRNAs from several biological-replicate samples, gives a 225 
mixture of individual responses and the results have been statistically demonstrated to be valid 226 
[35], [36, 37]. 227 
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 228 
2.6. Microarray processing 229 
Mouse Oligoset v3 (OPERON) arrays were used from the Genomics facility at the 230 
University of Cincinnati (USA). The slides contained 31,769 spotted probes (70 mer 231 
oligonucleotides) corresponding to 24,878 expressed or predicted mouse genes. Information on 232 
the printing and the oligo set can be found at http://microarray.uc.edu. The slides were 233 
prehybridized (42ºC, 45-60 min) in 6x SSC, 0.5% SDS and 1% BSA, and they were then rinsed 234 
10 times with distilled water. Fragmented Cy5 and Cy3 aRNA probes were mixed (110-150 pmol 235 
of each label) with 10 µg PolyA (Sigma-Aldrich, St. Gallen, Switzerland) and 5 µg Human Cot-236 
DNA (Invitrogen, part of Life Technologies, Carlsbad, CA, USA), and then dried in a speed-237 
vacuum. Each probe mix was resuspended in 60 µl of hybridization buffer (50% formamide, 6x 238 
SSC, 0.5% SDS, 5x Denhardt’s solution) and the probes were denatured at 95ºC for 5 min before 239 
they were applied to the slide using a LifterSlip (Erie Scientific Company, Portsmouth, NH, 240 
USA). The slides were incubated at 48ºC for 16 h in hybridization chambers (Array-It 241 
Corporation, Sunnyvale, CA, USA); in a water bath. After incubation, the slides were washed 242 
twice with 0.5x SSC, 0.1% SDS for 5 min each, three times with 0.5x SSC for 5 min, and finally 243 
in 0.05x SSC for 5 min, before they were dried by centrifugation (1600 r.p.m., 1 min). Images 244 
from the Cy3 and Cy5 channels were equilibrated and captured with an Axon 4000B scanner, and 245 
the spots were quantified using GenePix 5.1 software. Dye swapping replicates were performed 246 
for each particular hybridization, as described below (Data Analysis section). 247 
 248 
2.7. Data Analysis 249 
The raw data were processed using “AlmaZen” (Alma Bioinformatica, Tres Cantos, Spain) 250 
software. The background was subtracted from each individual hybridization and they were 251 
Lowess normalized [38]. For each condition, a technical replicate was performed by dye-252 
swapping (two hybridizations) in order to minimize a possible bias in the labeling process. The 253 
mean of log2 ratio (exposed/control) from the merge of the two dye-swapping hybridizations 254 
were calculated and p-values, standard deviations, and z-scores were obtained [39-41]. Raw and 255 
processed data were included in the Gene Expression Omnibus database (GEO) [42] (accession 256 
number GSE14774) following the Minimal Information About a Microarray Experiment 257 
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(MIAME) criteria [43]. 258 
 259 
2.8. Cluster analysis 260 
 To analyze transcriptome profiles in different experimental conditions, hierarchical 261 
clustering of array data has been used widely [44, 45]. Data were preprocessed previously to 262 
perform Hierarchical Clustering. Preprocessing included following criteria, using the “Preprocess 263 
DNA array data files” web tool (GEPAS v3.0) [46] [47]: merging values of gene replicates (by 264 
averaging), filtering missing values (70 % was the minimum percentage of missing values 265 
accepted), imputing missing values (using KNN impute) and filtering flat patterns by the 266 
numbers of peaks (a minimum of 3 peaks and a threshold of +0.7, in log scale, were considered). 267 
The distance matrix was calculated for both, genes and experimental conditions from the 268 
preprocessed datasets. The similarity metric used was a centered Pearson correlation. In addition, 269 
both genes and conditions were clustered by the Average Linkage method using Cluster 3.0 270 
software [48], and the clustering results generated by Cluster 3.0 were visualized using Java 271 
Treeview [49]. 272 
 We used this unsupervised hierarchical clustering analysis to organize the different 273 
conditions of exposure according to the similarity or dissimilarity of the gene expression profiles, 274 
situating the defined conditions of exposure with similar profiles together as neighboring 275 
columns in the clustergram. In addition, we analyzed the potential participation of gene 276 
signatures in molecular pathways as described in the results of the Ingenuity Pathway Analysis 277 
(http://www.ingenuity.com). 278 
 279 
2.9. Confirmation of microarray expression data by TaqMan® Low Density Arrays (TLDA) 280 
The expression of 23 genes randomly selected from the microarray analyses (Table S1 in 281 
supplemental material) was measured in custom TaqMan® Low Density Arrays (TLDA) 282 
(Applied Biosystems, part of Life Technologies, Carlsbad, CA, USA), following the 283 
manufacturer’s instructions. Expression was measured in the same RNA samples studied in the 284 
microarray experiments for each experimental condition. 285 
From the entire data set corresponding to the expression of the 23 selected genes (Table 286 
S1) obtained from all analyzed microarrays, only 130 expression values filtered for statistically 287 
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significant p-value (>0.05) were used for qualifying purposes. These data were compared with 288 
the corresponding data obtained by qRT-PCR. Statistical analyses of Pearson correlation and p-289 
value were performed using GraphPad Prism version 5.00 for Windows (GraphPad Software, San 290 
Diego, CA, USA; www.graphpad.com). 291 
 292 
3. Results 293 
 294 
The first aim was to evaluate the global change in levels of gene expression as effect of 295 
exposure to EDs in the different experimental conditions. From the microarray data, we used the 296 
average of the log-ratio approach adopted in the MicroArray Quality Control (MAQC) project to 297 
compare the toxicogenomic effects of different compounds [50]. To assess inter-individual gene 298 
expression level as a baseline in the testis from the CD-1 mice used, we performed preliminary 299 
analyses comparing RNA from three mice (S#1 vs S#2, S#1 vs S#3 and S#2 vs S#3) and from 300 
pooled testes (S#Pool vs S#Pool) obtained from at least three four-weeks old mice, neither 301 
exposed to compounds nor solvents. Fig. 2 shows the level of the global gene expression 302 
variation found in this comparative analysis in terms of the average of log-ratio from genes with 303 
an average signal higher than 64 in MA plots. Only raw and processed data from dye swapping 304 
replicates coming from pooled samples were included in the Gene Expression Omnibus database 305 
(GEO, accession number GSE14774), named as “Testis_Control”. 306 
After the analysis of the signal distribution in MA plots (data not shown), we only 307 
considered spots with an average signal >64 in order to avoid false background corresponding to 308 
genes weakly or negligibly expressed in the testis. We found that MEHP induced the strongest 309 
degree of global modification of gene expression of all the compounds analyzed (Fig. 2). The 310 
maximum effects were detected in those mice that were exposed throughout the entire period of 311 
development until they were analyzed (Fig. 2, exposure C). However, the results obtained from 312 
mice whose mothers were only exposed during the preovulatory pre-mating period indicated that 313 
some of the EDs analyzed, such as ZEA and MEHP, still induced gene expression modifications 314 
in the testes of the offspring, suggesting a maternal developmental reprogramming effect (Fig. 2, 315 
exposure A). Interestingly, this effect was more pronounced at lower rather than at higher 316 
concentrations. This “low dosage” effect was also detected following prolonged exposure to all 317 
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the EDs analyzed except for E2 (Fig. 2 exposure C). Furthermore, E2 had a weaker effect, at the 318 
dosages used, than most of the other ED compounds assessed, except at the maximum exposure. 319 
We extended this first global estimation to assess the level of global gene expression changes 320 
determining the total number of genes differentially expressed in the different experimental 321 
conditions under common filtering criteria. To increase the stringency of the analysis [50], we 322 
filtered the data to eliminate the results corresponding to genes that displayed weak expression 323 
and large variability. Hence, in this case, we only considered and analyzed the data corresponding 324 
to genes that underwent a change >+2- or <-2-fold, with a p-value <0.01 and an average signal 325 
>64. These results indicated a similar pattern of global gene expression changes as effect of the 326 
different exposures as when the average of the signals was the criterion for analysis (Fig. 3). 327 
To answer the question whether the profiles of expression, at the level of specific genes, 328 
were associated with specific EDs, the window of exposure during development and/or level of 329 
exposure, we carried out an analysis of the entire transcriptome data by unsupervised hierarchical 330 
clustering from dataset of all 45 different experimental conditions. The relationship between the 331 
exposure and the gene expression profile is depicted graphically as a dendrogram (Fig. 4). The 332 
filtering and pre-processing of the datasets indicated in the Materials and Methods defined 333 
specific gene expression signatures (involving 2,676 genes) for conditions corresponding to 334 
MEHP and ZEA exposures irrespective of the developmental stage or dose used (Fig. 4). Thus, 335 
for MEHP and ZEA the toxicogenomic effect in testis appears to be mediated by the nature of the 336 
compound rather than by the levels or the window of exposure during development. This also 337 
indicates that low dose exposure during the periconceptional period could result in deregulation 338 
of key genes in cellular functions of testicular cells in adulthood. 339 
 ZEA administration did not have a clear effect on morphological parameters other than a 340 
significant increase in the numbers of apoptotic cells after the middle dose group A, and the 341 
highest dose in exposure group B (Fig. S10 in supplemental material). However, MEHP did not 342 
cause any consistent morphological effect at any dose or exposure period (Fig. S11 in 343 
supplemental material). 344 
By contrast, the effect of E2 on global gene expression was not consistent across different 345 
samples and did not segregate these samples hierarchically from those exposed to BPA and LIN 346 
exposures. These data suggested that developmental exposure to MEHP or ZEA modulated gene 347 
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expression in a manner distinct to E2 and the other compounds assessed. Hence, the effects of 348 
these compounds on testicular development would appear to be mediated by mechanisms other 349 
than those affected by E2. In this hierarchical clustering it was possible to identify groups of 350 
genes preferentially expressed in specific cell types that might share putative functional 351 
properties. Following previous gene classifications in the testis [51], different "signatures" could 352 
be detected such as those expressed in round spermatids (Rtds I-V in grey bars, Fig. 4), as well as 353 
the groups of genes preferentially expressed in spermatid elongation (Fig. 4, EI-III in orange 354 
bars: Table S2 in supplemental material). 355 
Considering the results for E2, BPA and LIN, we studied whether we could define, 356 
through gene expression profiles, a pattern of response for these three EDs that could clarify 357 
similarities in their mechanism of action in testis development. For this reason, only data of the 358 
three compounds were reclustered. The profile of the dendogram was more tightly defined for the 359 
exposure to lindane up until birth (LB in the dendogram Fig. 5) or throughout the entire 360 
developmental period (LC: Fig. 5). It is noteworthy that there was a close linkage between the 361 
lowest level of exposure to LIN (LC+) and the highest level of E2 (EC+++) after prolonged 362 
exposure during development. However, the gene expression profiles for BPA and E2 were more 363 
interspersed, suggesting that BPA and E2 could act through similar mechanisms that differ from 364 
those used by the other compounds analyzed.  365 
The exposure to LIN had the strongest cytopathological effects on the seminiferous 366 
epithelium. Germ cell apoptosis strongly increased in all dose groups after exposure schedules B 367 
and C. In all these groups of B and C exposures the differences were statistically significant and 368 
moreover all three dose groups in exposure C showed decreased tubule diameters. In addition, 369 
significant changes in the frequency of epithelial abnormalities were seen for the two highest 370 
doses in group C. The percentages of tubules with diploid spermatids tended to increase parallel 371 
to the height of applied dose in exposure C, but the difference was only significant at the highest 372 
dose (Fig. S12 in supplemental material). 373 
Generally, exposure to the various compounds did not cause clear effects on body and 374 
relative testis weights. However, at the longest exposure period (group C) E2 did cause a 375 
decrease of about 30 % in body weight at all dose levels and an about 15% decrease in relative 376 
testis weight, was seen after exposure to LIN (Fig. S3-S7 in supplemental material). 377 
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 Exposure to E2 caused some particular effects on spermatogenic cells. Significant 378 
increases in numbers of apoptotic germ cells were detected in mice exposed according to 379 
experimental conditions B and C and receiving the highest doses of E2. Furthermore, clear 380 
decreases in tubule diameter and increased numbers of tubules with epithelial abnormalities were 381 
found with the high doses of E2 following exposure C. Remarkably, following exposure C 382 
diploid spermatids increased after all doses of E2 (Fig. S8 in supplemental material). 383 
 The effects of BPA administration were less than after E2 exposure. Only increases in the 384 
numbers of apoptotic germ cells were seen and only after exposure C and highest doses of BPA. 385 
No significant effects on the other parameters were seen after BPA administration (Fig. S9 in 386 
supplemental material). 387 
The data from the arrays were qualified by qRT-PCR (TaqMan probes). On the basis of 388 
the expression data in all experimental conditions from 23 genes randomly selected from those 389 
annotated in the clustering analysis, we considered eligible those data that showed statistical 390 
significance (p<0.05) in the microarray. A total of 130 expression values, fitting the mentioned 391 
statistical stringency, were compared with the data of expression by qRT-PCR. We found an 392 
expected correlation in this type of replication analysis between gene expression from the 393 
microarray analyses and the qRT-PCR results [52] (r=0.535 p< 0.0001; Fig. S2 in supplemental 394 
material). 395 
 By analyzing the genes that define the clusters using Ingenuity Pathway Analysis 396 
software (IPA), the highest scoring gene networks could be identified, those that were relevant to 397 
disorders related to the pathologies supposedly induced by EDs. Among the most relevant are 398 
diseases of the reproductive system: cancer, developmental and endocrine system disorders 399 
(Table 2). The canonical pathways with the highest values identified were the oxidative stress 400 
response mediated by Nrf2, protein ubiquitination, oxidative phosphorylation and mitochondrial 401 
dysfunction (Table 3). These pathways can also be considered as relevant to the mechanisms that 402 
potentially cause cell and developmental disorders related to the proposed effects of EDs on 403 
mammalian testis. 404 
The analysis of the networks of interacting genes was carried out only considering the 405 
genes defined in the hierarchical clustering, comparing all EDs and conditions. This means that 406 
the genes detected in each network are deregulated in at least three different conditions 407 
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(considering the criteria of 3 peaks of the clustering), and consequently, this does not mean that 408 
the changes in expression affect them equally with all EDs or in all conditions tested. However, 409 
these genes could be indicators of the pathways that may be more affected by individual ED or 410 
mixtures of EDs. The most representative network described a core of interacting genes that 411 
encode proteins involved in the global regulation of translation (Fig. 6 and Table S3 in 412 
supplemental material), as represented by the eukaryotic translation initiation factors (EIFS) and 413 
the cytoplasmic poly(A) binding protein (PABPC), critical post-transcriptional regulators. In 414 
addition members of the CCR4-NOT complex, such as Cnot1, Cnot7 and Cnot6, which interacts 415 
with PabpC1, were also detected in this most prominently affected network. Through its 416 
interaction with this network, the gene encoding the breast cancer anti-estrogen resistance 3 417 
protein (Bcar3) was also seen to be modified expression by all the ED’s analyzed. 418 
 419 
4. Discussion 420 
 421 
In this study we have compared global gene expression in testes of mice exposed to five 422 
endocrine disruptors, using three different doses and studying three distinct periods of 423 
developmental exposure. The main findings point out that Mono-(2-ethylhexyl)-phthalate and 424 
Zearalenone, more than 17β-Estradiol, Lindane or Bisphenol-A, produce specific gene signatures 425 
during testis development, irrespective of the concentration of the toxicant or the developmental 426 
period during which exposure takes place. These data suggest that prevalent alterations to defined 427 
networks can induce the disequilibrium in gene expression programs involved in correct 428 
testicular development and spermatogenesis, that can potentially be transmitted to male offspring 429 
in an epigenetic-like manner. However, histopathological study only showed moderate 430 
morphological abnormalities. 431 
In planning the dose range of each compound, we did not consider doses which cause 432 
acute toxicity but selected doses above the NOAEL and as the exposures were initiated in the 433 
mothers, we used doses that did not induce fetal loss. For some compounds such as E2 or BPA 434 
the doses used were below those that were considered to affect the number of births. In pilot 435 
experiments, for each compound we evaluated the rates of birth at different doses and 436 
developmental periods of exposure. In this way, a dietary concentration of intake of 100 437 
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µg/kg/day of E2 in CD1 mice was found to highly affect the number of successful pregnancies 438 
[53]. We confirmed this result and established the maximum dose at 48 µg/kg/day. Similarly, 439 
exposure of laboratory animals to BPA was reported to influence fertility [54] [7, 55]. To this 440 
respect, considering our scheme of experimental exposure during development, higher doses of 441 
compounds as E2 and BPA that potentially can induce severe effects on testis, were not be 442 
applied because the pregnancy of exposed mice was also clearly affected. This could explain the 443 
relative small effect detected in our study for E2 and BPA with respect to the level of gene 444 
deregulation in comparison to the other EDs evaluated.  445 
The tolerable daily intake (TDI) for lindane was originally estimated at 12.5 µg/kg 446 
bw/day [56]. However, lindane is a persistent contaminant and bioaccumulates. Traina et al. [57] 447 
using a similar dosage and method of administration as we used, reported long-lasting effects of 448 
lindane on mouse spermatogenesis without maternal toxicity or delayed growth and development 449 
of pups. 450 
With respect to MEHP, the ED with ZEA showing the most conspicuous effect of the 451 
compounds studied, a wide spectrum of human exposures to phthalates has been recently 452 
reviewed with estimations of intakes of DEHP varying between 7.3 µg to 409 µg/kg bw/day [58]. 453 
However, in higher exposed groups at risk such as premature neonates in a neonatal intensive-454 
care unit the estimated level can reach up to 6 mg/kg bw/day [59]. Maximal DEHP exposures up 455 
to 22 mg/kg bw/day have also been estimated for newborns infants following blood transfusion 456 
procedures [60]. These doses are equivalent to 45 mg/kg bw/day and 165 mg/kg bw/day 457 
respectively in the mouse, which is in the range of the median dose (46.3 mg/kg bw/day) or over 458 
maximum dose (92.7 mg/kg bw/day) used in the present study. This indicates that the defined 459 
pattern of altered gene expression detected in this study may be representative of the action of 460 
phthalates in exposed humans. Relevant expression patterns, with hundreds of deregulated genes, 461 
might not be associated to dramatic changes at the morphological or histological level in the 462 
testis, as it has been shown in this work. Previous studies reported that MEHP exposures cause an 463 
increase in apoptosis of germ cells in adult mice mediated by Sertoli cell injuries at 10 fold [50] 464 
or 20 fold the doses used in our study [51]. 465 
Worldwide, zearalenone is found in a number of cereal crops and derivatives. The 466 
concentrations of zearalenone in cereals vary over a wide range between 3 to 8000 µg/kg 467 
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(International Programme on Chemical Safety. WHO food additives series: 44, Geneva 2000 468 
http://www.inchem.org/documents/jecfa/jecmono/v44jec14.htm). However, high concentrations 469 
have been reported. For example: as zearalenone may be transmitted from contaminated grains 470 
into beer a very high concentration of zearalenone was found in beers brewed in Africa at levels 471 
of 53 mg/L [61]. Assuming an intake of 500 ml of beer per day, this is equivalent to 0.44 mg/kg 472 
bw/day. Applying the metabolic factor, this can be calculated to be 3.3 mg/kg bw/day for a 473 
mouse which is in the range of the medium dosage used in our study. Similar to MEHP, the 474 
specific profile of gene deregulation in testes from mice exposed to ZEA are not directly 475 
correlated with morphological alterations neither modifications of cellular composition in the 476 
seminifereous epithelium. However, the exposure to E2, BPA and LIN increased the numbers of 477 
apoptotic cells after the longest period of exposure but also when the treatment was stopped at 478 
birth, indicating long-term effects of these compounds. Epithelial abnormalities and 479 
modifications of tubule diameter showed increases at the highest dose of E2 and BPA or LIN 480 
after long-term exposure. 481 
Studies of the environmental induction of changes in gene regulation as disease etiology 482 
have focused on defined genes or genetic pathways related to particular diseases, including 483 
reproductive dysfunctions [24]. Estrogen has a crucial role during spermatogenesis [62] and 484 
hence, estrogen–like compounds can interfere with the activity of estrogen and its binding to 485 
estrogen receptors that mediates the transcription of target genes. However, the mechanisms by 486 
which estrogen regulates gene expression are known to be more complex than originally thought 487 
[63, 64]. The extensive alterations in gene expression observed in the present work can be 488 
explained by a cascade of effects triggered by environmental pollutants with the capacity to 489 
interfere with hormonal pathways (acting as EDs) and to lead to gene deregulation. 490 
Our results of global gene expression and the hierarchical clustering analysis suggest that 491 
some compounds considered as EDs could act via different mechanisms to estrogen. While 492 
MEHP [65] and ZEA [66] are considered to have estrogenic activity in vitro, they displayed 493 
distinct effects on gene expression that could not be considered to mimic those of estrogen, 494 
suggesting another mode of action. Indeed, it was recently reported that MEHP alters both 495 
steroidogenesis and germ cell number in mice, without involving either the estrogen or androgen 496 
receptor [33]. 497 
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In the hierarchical clustering, different signatures included the upregulation or 498 
downregulation of the same genes depending on the compound, dose or developmental period of 499 
exposure. Hence, it would appear that the effect of EDs cannot solely be attributed the reduced 500 
expression of genes specific to spermatids that might produce a lack or decrease in the number of 501 
these cell types (round or elongated), as suggested previously [67]. Indeed, alterations of the 502 
cytological structure of the seminiferous epithelium that could compromise spermatogenesis 503 
were not found in our cytological/histological analysis. Moreover, the results indicate that acute 504 
effects of the toxicants may not explain the altered gene expression since low doses and pre-505 
mating exposure of mothers induced the modulations of expression of genes in a clustered 506 
manner. 507 
In the present study, when the mothers were only exposed to EDs during the pre-mating 508 
period (exposure A), the level and type of gene modifications of gene expression observed in the 509 
offspring can only be attributed to epigenetic modifications in the oocyte/zygote, or during early 510 
embryonic development prior to gonadal sex differentiation if traces of the compound remained 511 
in the maternal metabolism. No epigenetic transgenerational effect of ZEA, MEHP or LIN has 512 
been reported previously. In rats exposed to vinclozolin, a fungicide considered to be an ED, 513 
effects on the male reproductive system were evident until the F4 generation [68] and they were 514 
attributed to epigenetic effects. Although, the transgenerational effects of orally administered 515 
vinclozolin were recently questioned [69], alterations to the transcriptome have been 516 
demonstrated in rat embryonic testis in the F1 to F3 generations when the F0 generation was 517 
exposed to vinclozolin from day 8 to 14 of gestation [70]. This exposure coincides with a period 518 
when epigenetic reprogramming occurs in the transition of primordial germ cells to sex-519 
differentiated germ cells [71]. The transgenerational effect of some of the EDs that we have 520 
analyzed should also be evaluated further at the promoter level on the basis of specific potential 521 
epigenetic alterations. 522 
By analyzing gene expression signatures in relation to their biological pathways, 523 
oxidative stress response mediated by NF-E2-related factor 2 (Nrf2) was detected as a 524 
particularly relevant pathway that could be altered as response to the different EDs. Nrf2 is a 525 
transcription factor that acts through the antioxidant response element [72]. The expression of 526 
mitochondrial and nuclear-encoded subunits of respiratory chain complexes must be closely 527 
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coordinated, and Nrf1 and Nrf2 are the main genes responsible for this coordination. Testicular 528 
oxidative stress appears to be a common feature of male infertility and indeed, exposure to 529 
toxicants has been correlated with an increase in oxidative stress in the testis [73]. These data 530 
suggest that in the testis, EDs modify the expression of genes involved in pathways common to 531 
other xenobiotics described in the literature that clearly affect reproduction, even when the 532 
compound is administered to the mother prior to fertilization. 533 
In the most relevant networks of genes involved in post-transcriptional regulation, 534 
regulators such as EIF and poly-A binding protein occupy a central position. Five genes 535 
encoding different isoforms of EIF4 (Eif4A1, Eif4A2, Eif4E, Eif4G1, and Eif4G2) and three 536 
encoding EIF3 isoforms (Eif3B, Eif3E, Eif3H), together with Pabpc, participate in the core of the 537 
43S pre-initiation ribosomal complex, binding mRNAs prior to translation [74]. These nine 538 
genes showed different altered expression under different experimental conditions. The EIF4F 539 
complex is composed of EIF4E, EIF4G and EIF4A, and it associates with the 5’ cap structure of 540 
the mRNA as part of the 43S preribosomal complex. This EIF4F complex is largely dependent 541 
on the availability of EIF4E, which thereby limits the rate at which translation is initiated [75]. 542 
Eif4E overexpression has long been associated with oncogenesis [76] and there is increasing 543 
evidence correlating it with cellular transformation, tumorigenesis and metastatic progression in 544 
human cancers [77]. However, experimental downregulation of Eif4E induces apoptosis [75]. 545 
The modification of Eif and Pabpc expression after exposure to EDs may involve 546 
downregulation or upregulation depending on the compound used and the period of 547 
developmental exposure. Although, the general tendency was a diminution of their expression, 548 
compared to the controls, as seen for Eif4E, Eif3E, Eif4A2, after MEHP exposure we detected an 549 
increase in the expression of Eif4A1.  550 
Post-transcriptional regulation of most mRNAs is mediated by the length of their 3’ 551 
poly[A] tails. PABP acts by promoting mRNA translation and several deadenylases serve as 552 
antagonists, facilitating the degradation of the mRNA [78]. PABPC1 interacts with subunits of 553 
the CCR4-NOT complex. Mammalian CCR4-NOT represents a complex of several subunits that 554 
acts as a deadenylase for mRNAs [79]. A recent study indicated that CCR4-NOT participates in 555 
the regulation of certain endogenous retinoic acid receptors that are essential for normal 556 
spermatogenesis [80]. The association and combination of different subunits in this complex 557 
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modulate different specific cell functions [81]. Three components of this complex in the 558 
network: Cnot1, Cnot6 and Cnot7 were deregulated in different ways. CNOT1 represses the 559 
ligand–dependent transcriptional activity of the estrogen receptor (ER)α receptor [82]. Indeed, in 560 
all conditions both E2 and MEHP exposure diminishes the amount of Cnot1 mRNA compared to 561 
the controls. CNOT7 acts as a co-regulator of retinoid X receptor beta (Rxrb) and significantly, 562 
male null mutant mice (Cnot7-/-) are sterile due to oligo-astheno-teratozoospermia resulting from 563 
Sertoli cell defects [83]. Moreover, the expression of Cnot7 was downregulated following 564 
exposure to all compounds and conditions, except ZEA. 565 
The data obtained suggest that global translation of cap-dependent mRNAs, mediated by 566 
the initiation complexes, may be deregulated through the disequilibrium in the availability of the 567 
components of these complexes. Accordingly, phenotypic alterations may be promoted that 568 
range from apoptosis to cellular transformation and cancer, depending on the cell type and 569 
developmental stage. In addition, modification of expression of genes encoding proteins that 570 
interact with hormone receptors, such as Cnot, can have a variety of pathological consequences 571 
during testicular development, already proposed to be effects of ED exposure. We speculate that 572 
the disequilibrium in different elements of these complexes and associated genes/proteins 573 
provoke different pathologies during testes development that can be attributed to different 574 
nosological entities. 575 
It is interesting to note that in the network the Bcar3 gene is connected to Pabpc1 and its 576 
level of expression was also altered. The genes of the Bcar family contribute to cell proliferation 577 
in estrogen-independent breast cancer and hence, these cells are resistant to anti-estrogen 578 
endocrine therapy [84]. We speculate that this gene may also participate in some alterations of 579 
the endocrine response in germ cells. 580 
Besides emphasizing the comparative results of the effect of different compounds, doses 581 
and exposure periods, the data points of more than 3 million quantitative values of expression 582 
levels of genes expressed in testis that we have included in GEO (Accession number GSE14774) 583 
may be of significant value in further comparative studies to determine potential mechanisms of 584 
action and biomarkers of the effects of endocrine disrupters. 585 
 586 
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FIGURE LEGENDS: 811 
 812 
Figure 1. Schedule of ED exposures and their controls. Three exposure regimes were 813 
employed: mothers were exposed for two weeks before mating only (exposure A) or the exposure 814 
was maintained during embryonic and fetal development, ceasing at birth (exposure B) or at the 815 
end of the prepubertal stage (exposure C). Three ED concentrations were used for each 816 
developmental period of exposure. All male offspring were orchidectomized at four weeks of age 817 
to obtain the total RNA. The solvents of each ED (DMSO or ethanol) were used as controls. 818 
 819 
Figure 2. Assessment of global gene expression changes. Graph representing the calculated 820 
average of the log2 (R/G) obtained from the microarray expression data. Basal Gene Expression 821 
Average (BGEA) from testis was obtained by hybridization of individual and pooled RNA 822 
samples from testes neither exposed to compounds nor solvents (S#1 vs S#2 = individual sample 823 
1 versus individual sample 2; S#1 vs S#3 = individual sample 1 versus individual sample 3; S#2 824 
vs S#3 = individual sample 2 versus individual sample 3; S#pool =pooled sample versus itself). 825 
Only the expression data from genes with average signals higher than 64 were considered. Grey 826 
triangles indicate the increasing doses of the compounds. 827 
 828 
Figure 3. Total number of genes with altered gene expression. The total number of genes 829 
induced and repressed (fold change >+2 and <-2, p-value <0.01 and an average signal >64) in all 830 
the conditions analyzed. 831 
 832 
Figure 4. Hierarchical clustering. Dendogram of the unsupervised hierarchical clustering 833 
performed with filtered and pre-processed (3 peaks and a threshold of 0.7) expression data from 834 
each experimental condition (see methods). After processing the datasets, 2,676 genes were 835 
considered for clustering. Each column represents a specific exposure regime. The codes are 836 
made up of the first letter of the compound (L-LIN; E-E2; Z-ZEA; M-MEHP and B-BPA), a 837 
second letter representing the developmental period of exposure (pre-mating = A; embryonic and 838 
fetal = B; postnatal = C), followed by the dosage in brackets (see Fig. 1). Each experimental 839 
compound is depicted with a specific color to readily visualize the clustered conditions (blue for 840 
28 
 
 
LIN, magenta for E2, yellow for ZEA, light green for MEHP, brown for BPA). Orange and grey 841 
bars denote gene clusters that include the genes preferentially expressed during spermiogenesis or 842 
in round spermatids, respectively. The color scale of expression (log2 ratio) is shown. 843 
 844 
Figure 5. Clustering of LIN, BPA and E2 conditions. Unsupervised hierarchical clustering 845 
performed with filtered and pre-processed expression data (3 peaks and a threshold of 0.7) after 846 
exposure to LIN, BPA and E2 (all exposures excluding MEHP and ZEA). After processing the 847 
datasets, 666 genes were considered for clustering. The color scale of expression (log2 ratio) is 848 
shown. 849 
 850 
Figure 6. Identified gene networks. The top ranked networks identified by Ingenuity Pathway 851 
Analysis (IPA) software from the genes selected for hierarchical clustering considering all the 852 
experimental regimes of exposure. Shaded genes represent those that were included in the 853 
geneset analyzed by IPA. 854 
855 
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Table 1. Compound dosages administrated to mice in the drinking water (estimated intake in 856 
mg/kg/day). 857 
 858 
Escalation 
Estradiol 
(E2) 
Bisphenol-A 
(BPA) 
Zearalenone 
(ZEA) 
Mono (2-
EthylHexyl) 
Phthalate 
(MEHP) 
Lindane 
(LIN) 
Dose (+) 0.006 0.16 1.3 9.2 16.6 
Dose (++) 0.012 16 3.9 46.3 32.2 
Dose (+++) 0.048 64 6.6 92.7 64.4 
 859 
 860 
 861 
 862 
Table 2. Top associated network functions identified by Ingenuity Pathway Analysis 863 
considering genes selected by hierarchical clustering of all experimental conditions.  864 
Associated network functions  Score  
Cancer, cell cycle, reproductive system disease 43 
Cellular functions and maintenance, developmental disorders , genetic 
disorders 
43 
Molecular transport, protein trafficking, endocrine system development and 
function  
41 
Drug metabolism, small molecule biochemistry, cell cycle 38 
RNA post-transcriptional modification, protein synthesis, gene expression 36 
 865 
 866 
 867 
 868 
 869 
 870 
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Table 3. Top canonical pathways identified by Ingenuity Pathway Analysis considering genes 871 
selected by hierarchical clustering of all experimental conditions. 872 
Pathways  p-value  
Nrf2-mediated oxidative 
stress response 
0.0000000165 
Protein ubiquitination 
pathway 
0.00000011  
Oxidative phosphorylation  0.000000464  
Mitochondrial dysfunction 0.00000118  
Ubiquinone biosynthesis 0.000142  
 
 
 


















Table S1. Genes selected for quantitative real-time PCR validation purposes and their 
functions. 
Gene Name Gene Symbol Function Process 
chromatin modifying 
protein 4B Chmp4b 
Transfer/carrier protein, Other 
transfer/carrier protein Intracellular protein traffic 
spermatogenesis 
associated 18 Spata18 Molecular function unclassified Biological process unclassified 
ect2 oncogene Ect2 Select regulatory molecule, G-protein modulator Oncogenesis 
eukaryotic translation 
initiation factor 5A2 Eif5a2 
Nucleic acid binding, 
Translation factor, Translation 
initiation factor 
Protein metabolism and modification, 
Protein biosynthesis 
prominin 1 Prom1 Membrane traffic protein Intracellular protein traffic, Other intracellular protein traffic 
Yip1 domain family, 
member 5 Yipf5 Molecular function unclassified Biological process unclassified 
DnaJ (Hsp40) homolog, 
subfamily B, member 8 Dnajb8 Chaperone, Other chaperones 
Protein metabolism and modification, 
Protein folding 
spermatid associated Spert Molecular function unclassified Biological process unclassified 
RAB5A, member RAS 
oncogene family Rab5a 
Select regulatory molecule, G-
protein, Small GTPase 
Signal transduction, Intracellular 
protein traffic, General vesicle 
transport, Exocytosis, Regulated 
exocytosis, Endocytosis, Receptor 
mediated endocytosis 
NADH dehydrogenase 
(ubiquinone) 1 alpha 
subcomplex, 13, testis-
specific serine kinase 6 
Ndufa13,Tssk6 
Molecular function 
unclassified, Kinase, Protein 
kinase, Non-receptor 
serine/threonine protein kinase 
Biological process unclassified, 
Protein metabolism and modification, 
Protein modification, Protein 
phosphorylation 
A kinase (PRKA) anchor 
protein 3 Akap3 
Select regulatory molecule, 
Kinase modulator 
Protein targeting and localization, 
Protein targeting 
ubiquitin specific 
peptidase 2 Usp2 Protease, Cysteine protease 
Protein metabolism and modification, 
Proteolysis 
small nuclear RNA 
activating complex, 
polypeptide 2 
Snapc2 Transcription factor, Basal transcription factor 
Nucleoside, nucleotide and nucleic 
acid metabolism, mRNA 
transcription, mRNA transcription 
regulation 
ring finger protein (C3HC4 
type) 19 Rnf19 Molecular function unclassified 
Protein metabolism and modification, 
Protein modification, Cell structure 
and motility, Cell structure 
retinoblastoma-like 2 Rbl2 
Transcription factor, Other 
transcription factor, Nucleic 
acid binding 
Nucleoside, nucleotide and nucleic 
acid metabolism, mRNA 
transcription, mRNA transcription 
regulation, Oncogenesis, Tumor 
suppressor, Cell cycle, Cell cycle 
control 
cell adhesion molecule 
with homology to L1CAM Chl1 
Cell adhesion molecule, CAM 
family adhesion molecule 
Signal transduction, Cell 
communication, Cell adhesion-
mediated signaling, Developmental 
processes, Ectoderm development, 
Neurogenesis, Cell adhesion 
defensin beta 19 Defb19 Molecular function unclassified Biological process unclassified 
ring finger protein 10 Rnf10 Molecular function unclassified Biological process unclassified 
glycoprotein, synaptic 2 Gpsn2 Oxidoreductase, Dehydrogenase Biological process unclassified 
zinc finger, FYVE domain 
containing 9 Zfyve9   
testis derived transcript Tes Nucleic acid binding Electron transport, Other metabolism 
phospholipid scramblase 
2 Plscr2   
cullin 3 Cul3 Miscellaneous function, Other miscellaneous function protein 
Protein metabolism and modification, 
Proteolysis, Oncogenesis, Cell cycle, 
Cell cycle control, Apoptosis, 
Induction of apoptosis 
 
Table S2. Genes preferentially expressed in spermiogenesis (EI-EIII) and round 
spermatids (Rtds I-V) that appear co-clustered in Figure 3 (EI-III, orange bars, 
and Rtds I-V, grey bars). 
 
 
E-I 
Gene Ref seq DNA Description Ensembl* Chr   
Tax1bp1 NM_025816.1 Tax1 (human T-cell leukemia virus type I) binding protein 1 6   
Col4a3bp NM_023420.1 Procollagen, type IV, alpha 3 (Goodpasture antigen) binding protein 13   
Clpx NM_011802.1 caseinolytic peptidase X (E.coli) 9   
Iqwd1 AK161893 IQ motif and WD repeats 1 1   
1700007B14Rik AK077102 Adult male testis cDNA, IQ calmodulin-binding motif containing protein 8   
Anubl1 AK089032 AN1, ubiquitin-like, homolog (Xenopus laevis) 6   
Psma6 NM_011968.1 proteasome (prosome, macropain) subunit, alpha type 6 12   
Mjd NM_029705.1 Machado-Joseph disease (ataxin 3) homolog (human) 12   
Vashl NM_144879.1 Vasohibin-like protein 1   
Otud4 AK122429 OTU domain containing 4 8   
Cpeb4 NM_026252.2 cytoplasmic polyadenylation element binding protein 4 11   
Cast NM_009817.1 Calpastatin, mRNA (cDNA clone MGC:12116 IMAGE:3710078) 13   
Trim36 NM_178872.3 Tripartite motif-containing 36, mRNA  18   
Dgkh    XM_484397 similar to diacylglycerol kinase, eta isoform 1  14   
Tnp1 NM_009407.1 transition protein 1 1   
Hils1 NM_018792.1 histone H1-like protein in spermatids 1 11   
1700010M22Rik NM_025490.1 SIMILARITY: Contains 1 SCP2 domain 2   
Psme4 NM_134013.2 Proteasome (prosome, macropain) activator subunit 4, mRNA  11   
 
E-II 
Gene Ref seq DNA Description Ensembl* Chr   
Prkcd NM_011103.1 Protein kinase C, delta (Prkcd) 14   
Sh3bp5 NM_011894.1 SH3-domain binding protein 5 (BTK-associated) 14   
Nt5c1b NM_027588.2 5'-nucleotidase, cytosolic IB 12   
Cdrt4 NM_025496.1 CMT1A duplicated region transcript 4 11   
Isg20l2 NM_177663.2 interferon stimulated exonuclease gene 20-like 2 3   
Q9DC38 AK004585 Adult male lung cDNA hypothetical protein 12   
4931440F15Rik NM_176829.1 hypothetical protein LOC216622 11   
Sstk NM_032004.1 Serine/threonine protein kinase SSTK (Sstk) 8   
Tssk2 NM_009436.1 Testis-specific serine kinase 2 (Tssk2) 16   
1700003N22Rik NM_145538.1 similar to Ubiquitin-conjugating enzyme variant Kua  2   
2810453I06Rik  NM_026050.1 hypothetical protein LOC67238  5   
Aif1 NM_019467.2 Allograft inflammatory factor 1 17   
Nup35 NM_027091.1 nucleoporin 35 2   
D2Ertd750e NM_026412.1 TRAF4 associated factor 1 homolog 2   
1700012A03Rik NM_029587.1 hypothetical protein LOC76382 6   
Dnajb8 NM_019964.1 DnaJ (Hsp40) homolog, subfamily B, member 8 (Dnajb8) 6   
Csnk1g2 NM_134002.1 casein kinase 1, gamma 2 10   
Spata18 NM_178387.2 Spermatogenesis associated 18 homolog (rat)  5   
Fscn3 NM_019569.2 Fascin homolog 3, actin-bundling protein, testicular (S. purpuratus)  6   
Otub2 NM_026580.1 OTU domain, ubiquitin aldehyde binding 2 12   
Dp1l1 NM_139292.1 Deleted in polyposis 1-like 1 (Dp1l1), mRNA 10   
Gsg1 NM_010352.1 Germ cell-specific gene 1 6   
4931407G18Rik NM_027631.1 testis development protein NYD-SP26 5   
Rnf138 NM_019706.2 Ring finger protein 138, transcript variant 2 18   
Iqcf3 NM_026645 IQ motif containing F3 9   
5730596K20Rik  NM_146091.2 hypothetical protein LOC109168 19   
1700029H14Rik  NM_025601.1 hypothetical protein LOC66501 8   
Ppm1a NM_008910.2 protein phosphatase 1A, magnesium dependent, alpha isoform 12   
Psmf1 NM_144889.2 proteasome (prosome, macropain) inhibitor subunit 1 2   
Skd3 NM_009191.2 Suppressor of K+ transport defect 3 (Skd3), mRNA 7   
Spata19 NM_029299.1 spermatogenesis associated 19 9   
R3hcc1 BC059860 R3H domain and coiled-coil containing 1 14   
Pdzk1 NM_021517.1 PDZ domain containing 1 3   
Nurit NM_026457.1 Testis-specific leucine zipper protein nurit mRNA,  14   
Adam1a NM_172126.2 Fertilin alpha precursor (ADAM 1) 5   
4930431B09Rik BC046309 PREDICTED 3   
Tisp78 NM_144827.3 Spermatogenesis associated 20 11   
Mfap3l NM_027756.2 Microfibrillar-associated protein 3-like 8   
Chn2 NM_023543.1 chimerin (chimaerin) 2 6   
Tmco5 NM_026104.1 transmembrane and coiled-coil domains 5 2   
5031400M07Rik NM_020586.1 hypothetical protein LOC80517 9   
Fts NM_010241.1 Fused toes, mRNA  8   
1700009N14Rik XM_131323 hypothetical protein LOC75471 4   
Ppp2r2b NM_027531.1 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52) 18   
Akap4 NM_009651.1 A kinase (PRKA) anchor protein 4 (Akap4), mRNA X   
4921517D22Rik NM_183290.1 hypothetical protein LOC70900 13   
Tmem56 NM_178936.2 Transmembrane protein 56 (Tmem56) 3   
Mgat4a NM_173870.1 mannoside acetylglucosaminyltransferase 4, isoenzyme A 1   
1700029J11Rik  AK006503 Adult male testis cDNA, product:hypothetical protein 2   
Ube2v2 NM_023585.2 Ubiquitin-conjugating enzyme E2 variant 2 (Ube2v2) 16   
4933417A18Rik NM_025750.1 hypothetical protein LOC66761 13   
Odf2 NM_013615.1 outer dense fiber of sperm tails 2 2   
Orc3l NM_001007589.1 origin recognition complex, subunit 3-like (S. cerevisiae) 4   
4921530L21Rik NM_025733.1 hypothetical protein LOC66732 14   
4921530D09Rik AK014983 Adult male testis cDNA, hypothetical protein 2   
1700011H14Rik NM_025956.2 hypothetical protein LOC67082 14   
Ccdc50  NM_001025615.1 Coiled-coil domain-containing protein 50 (Protein Ymer) 16   
4921528O07Rik AK019544 Adult male testis cDNA, hypothetical ARM repeat containing protein 1   
Plcz1 NM_054066.2 Phospholipase C, zeta 1 (Plcz1), mRNA 6   
Hip2 NM_016786.2 Huntingtin interacting protein 2 5   
Spag4l NM_029599.1 Sperm associated antigen 4-like (Spag4l), mRNA 2   
Tes NM_011570.2 Testin, testis derived transcript (Tes), transcript variant 1 6   
Gpd2 NM_010274.2 glycerol phosphate dehydrogenase 2, mitochondrial 2   
Lnp NM_027133.1 limb and neural patterns 2   
Zp3r NM_009581.1 Zona pellucida 3 receptor (Zp3r), mRNA 1   
Sec24b NM_207209.1 SEC24 related gene family, member B (S. cerevisiae)  3   
Pdia3 NM_007952.1 protein disulfide isomerase associated 3 2   
 
E-III      
Gene Ref seq DNA   Description Ensembl* Chr   
Fabp3 NM_010174.1 fatty acid binding protein 3, muscle and heart 4   
1700023L04Rik AK076883 hypothetical protein LOC76419  6   
Thrap3 NM_025856.1 thyroid hormone receptor associated protein 3 4   
Dnajb13 NM_153527.2 DnaJ (Hsp40) related, subfamily B, member 13 7   
4930579J09Rik NM_133689.1 IIIG9 protein, a novel mRNA expressed along brain ventricles 19   
Stard10 NM_019990.1 START domain containing 10 (Stard10), mRNA 7   
Osbp2 NM_152818.2 Oxysterol binding protein 2 (Osbp2), mRNA 11   
Arpm2 NM_028513.2 Actin related protein M2 (Arpm2), mRNA 4   
4930579G22Rik NM_026916.1 hypothetical protein LOC69034 5   
1700056E22Rik AK006811 hypothetical protein LOC73363 1   
1700054O13Rik NM_026096.1 Huntingtin interacting protein M X   
Nr1d1 NM_145434.1 Nuclear receptor subfamily 1, group D, member 1 (Nr1d1) 11   
BC051628 NM_199312.1 hypothetical protein LOC332713  2   
      
Rtids-I      
Gene Ref seq DNA Description Ensembl* Chr   
Ddx20 NM_017397.2 DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 (Ddx20), mRNA 3   
Col4a3bp NM_023420.1 Procollagen, type IV, alpha 3 (Goodpasture antigen) binding protein 13   
4921521K07Rik NM_027599.1 hypothetical protein LOC70902 5   
Ngly1 NM_021504.2 N-glycanase 1 (Ngly1), mRNA 14   
1700007B14Rik AK077102 IQ Calmodulin binding motif containing protein  8   
Anubl1 AK089032 AN1, ubiquitin-like, homolog (X. laevis) 6   
Psma6 NM_011968.1 proteasome (prosome, macropain) subunit, alpha type 6 12   
Tsnaxip1 NM_024445.2 translin-associated factor X (Tsnax) interacting protein 1 8   
Mjd NM_029705.1 Machado-Joseph disease (ataxin 3) homolog (human) 12   
4631422O05Rik BC062166  4631422O05 gene 16   
B130052G07Rik NM_144879.1 Vasohibin-like protein 1   
Otud4 AK122429 OTU domain containing 4/HIV-1 induced protein HIN-1 8   
Cpeb4 NM_026252.2 cytoplasmic polyadenylation element binding protein 4 11   
Trim36 NM_178872.3 Tripartite motif-containing 36, mRNA  18   
Dgkh XM_484397 M. musculus diacylglycerol kinase, eta, transcript variant 1 14   
4932412H11Rik NM_172879.1 hypothetical protein LOC242838 5   
Tnp1 NM_009407.1 transition protein 1 1   
Hils1 NM_018792.1 histone H1-like protein in spermatids 1 11   
1700010M22Rik NM_025490.1 SIMILARITY: Contains 1 SCP2 domain 2   
 
Rtds-II      
Gene Ref seq DNA Description Ensembl* Chr   
Prkcd NM_011103.1 Protein kinase C, delta (Prkcd), mRNA 14   
Nt5c1b NM_027588.2 5'-nucleotidase, cytosolic IB 12   
Cdrt4 NM_025496.1 CMT1A duplicated region transcript 4 11   
Isg20l2 NM_177663.2 interferon stimulated exonuclease gene 20-like 2 3   
Q9DC38 AK004585                 Adult male lung cDNA hypothetical protein 12   
Sstk NM_032004.1 Serine/threonine protein kinase SSTK (Sstk) 8   
Tssk2 NM_009436.1 Testis-specific serine kinase 2 (Tssk2), mRNA 16   
2810453I06Rik  NM_026050.1 hypothetical protein LOC67238  5   
Aif1 NM_019467.2 Allograft inflammatory factor 1, mRNA) 17   
1700012A03Rik NM_029587.1 hypothetical protein LOC76382 6   
Dnajb8 NM_019964.1 DnaJ (Hsp40) homolog, subfamily B, member 8 (Dnajb8) 6   
Csnk1g2 NM_134002.1 casein kinase 1, gamma 2 10   
Spata18 NM_178387.2 Spermatogenesis associated 18 homolog (rat)  5   
Fscn3 NM_019569.2 Fascin homolog 3, actin-bundling protein, testicular (S. purpuratus)  6   
Otub2 NM_026580.1 OTU domain, ubiquitin aldehyde binding 2 12   
Gsg1 NM_010352.1 Germ cell-specific gene 1, mRNA 798) 6   
4931407G18Rik NM_027631.1 testis development protein NYD-SP26 5   
Rnf138 NM_019706.2 Ring finger protein 138, transcript variant 2, mRNA  18   
1700023E05Rik NM_027970.1 hypothetical protein LOC71868 5   
Iqcf3 NM_026645 IQ motif containing F3, mRNA  9   
5730596K20Rik  NM_146091.2 hypothetical protein LOC109168 19   
1700029H14Rik  NM_025601.1 hypothetical protein LOC66501 8   
Psmf1 NM_144889.2 proteasome (prosome, macropain) inhibitor subunit 1 2   
Skd3 NM_009191.2 Suppressor of K+ transport defect 3 (Skd3), mRNA 7   
Spata19 NM_029299.1 spermatogenesis associated 19 9   
Agpat3 NM_053014.2 1-acylglycerol-3-phosphate O-acyltransferase 3 (Agpat3) 10   
R3hcc1 BC059860 R3H domain and coiled-coil containing 1 14   
Pdzk1 NM_021517.1 PDZ domain containing 1 3   
Rnf38 NM_175201.2 Ring finger protein 38, mRNA  4   
Nurit NM_026457.1 Testis-specific leucine zipper protein nurit), alternatively spliced 14   
Adam1a NM_172126.2 Fertilin alpha precursor (ADAM 1) 5   
4930431B09Rik BC046309 PREDICTED 3   
Tisp78 NM_144827.3 Spermatogenesis associated 20, mRNA) 11   
Wdr51b NM_027740.3 WD repeat domain 51B 10   
Mfap3l NM_027756.2 Microfibrillar-associated protein 3-like, mRNA:5025281) 8   
4930435E12Rik AK077164 PREDICTED: similar to hypothetical protein FLJ32859 16   
 NM_001013783.1 hypothetical protein LOC432552  11   
Chn2 NM_023543.1 chimerin (chimaerin) 2 6   
Tmco5 NM_026104.1 transmembrane and coiled-coil domains 5 2   
5031400M07Rik NM_020586.1 hypothetical protein LOC80517 9   
1700009N14Rik AK005799 hypothetical protein LOC75471  4   
Akap4 NM_009651.1 A kinase (PRKA) anchor protein 4 (Akap4), mRNA X   
4921517D22Rik NM_183290.1 hypothetical protein LOC70900 13   
 
Rtds-III      
Gene Ref seq DNA Description Ensembl* Chr   
4921530L21Rik NM_025733.1 hypothetical protein LOC66732 14   
4921530D09Rik AK014983 adult male testis cDNA, hypothetical protein 2   
1700011H14Rik NM_025956.2 hypothetical protein LOC67082 14   
Ccdc67 NM_181816.1 coiled-coil domain containing 67 9   
4921528O07Rik AK019544 Adult male testis cDNA, hypothetical ARM repeat structure  1   
Plcz1 NM_054066.2 Phospholipase C, zeta 1 (Plcz1), mRNA 6   
Chl1 NM_007697.1 Cell adhesion molecule with homology to L1CAM  6   
 
Rtds-IV      
Gene Ref seq DNA Description Ensembl* Chr   
Tesp1 NM_009355.1 Testicular serine protease 1 (Tesp1), mRNA 1   
Spag4l NM_029599.1 Sperm associated antigen 4-like (Spag4l), mRNA 2   
Tekt2 NM_011902.1 Tektin 2, mRNA (cDNA clone MGC:5692 IMAGE:3582971) 4   
1700025E21Rik NM_029373.1 hypothetical protein LOC75647 6   
Tes NM_011570.2 Testin, testis derived transcript (Tes), transcript variant 1 6   
Gpd2 NM_010274.2 glycerol phosphate dehydrogenase 2, mitochondrial 2   
Rnf139 NM_175226.2 Ring finger protein 139, mRNA  15   
Lnp NM_027133.1 limb and neural patterns 2   
Zp3r NM_009581.1 Zona pellucida 3 receptor (Zp3r), mRNA 1   
 
Rtds-V      
Gene Ref seq DNA Description Ensembl* Chr   
1700023L04Rik AK076883 Adult male testis cDNA, hypothetical protein 6   
1700110M21Rik AK007164 Adult male testis cDNA,  hypothetical protein 14   
Thrap3 NM_025856.1 thyroid hormone receptor associated protein 3 4   
Dnajb13 NM_153527.2 DnaJ (Hsp40) related, subfamily B, member 13 7   
4930579J09Rik NM_133689.1 IIIG9 protein, a novel mRNA expressed along brain ventricles 19   
Arpm2 NM_028513.2 Actin related protein M2 (Arpm2), mRNA 4   
4930579G22Rik NM_026916.1 hypothetical protein LOC69034  5   
1700054O13Rik NM_026096.1 Huntingtin interacting protein M X   
BC051628 NM_199312.1 hypothetical protein LOC332713  2   
 
Table S3. Genes included in the most representative network from the hierarchical clustering 
analysis considering all experimental conditions of exposure 
 
Symbol Entrez Gene Name Location Family 
BCAR3 breast cancer anti-estrogen resistance 3 Cytoplasm other 
C9ORF9 chromosome 9 open reading frame 9 Unknown other 
CD48 CD48 molecule Plasma 
Membrane 
other 
CNOT1 CCR4-NOT transcription complex, subunit 1 Unknown other 
CNOT6 CCR4-NOT transcription complex, subunit 6 Nucleus other 
CNOT7 CCR4-NOT transcription complex, subunit 7 Nucleus transcription 
regulator 
DDX24 DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 Nucleus enzyme 
EEF1D eukaryotic translation elongation factor 1 delta 
(guanine nucleotide exchange protein) 
Cytoplasm translation 
regulator 
EGLN2 egl nine homolog 2 (C. elegans) Cytoplasm enzyme 
EIF3B eukaryotic translation initiation factor 3, subunit B Cytoplasm translation 
regulator 
EIF3E eukaryotic translation initiation factor 3, subunit E Cytoplasm translation 
regulator 
EIF3H eukaryotic translation initiation factor 3, subunit H Cytoplasm translation 
regulator 
EIF4A1 eukaryotic translation initiation factor 4A, isoform 
1 
Cytoplasm translation 
regulator 
EIF4A2 eukaryotic translation initiation factor 4A, isoform 
2 
Cytoplasm translation 
regulator 
EIF4E eukaryotic translation initiation factor 4E Cytoplasm translation 
regulator 
EIF4G1 eukaryotic translation initiation factor 4 gamma, 1 Cytoplasm translation 
regulator 
EIF4G2 
(includes 
EG:1982) 
eukaryotic translation initiation factor 4 gamma, 2 Cytoplasm translation 
regulator 
FABP3 fatty acid binding protein 3, muscle and heart 
(mammary-derived growth inhibitor) 
Cytoplasm transporter 
FABP4 fatty acid binding protein 4, adipocyte Cytoplasm transporter 
FOXE1 forkhead box E1 (thyroid transcription factor 2) Nucleus transcription 
regulator 
GUCY2C guanylate cyclase 2C (heat stable enterotoxin 
receptor) 
Plasma 
Membrane 
kinase 
HK1 hexokinase 1 Cytoplasm kinase 
HMOX2 heme oxygenase (decycling) 2 Cytoplasm enzyme 
Insulin  Unknown group 
MDH2 malate dehydrogenase 2, NAD (mitochondrial) Cytoplasm enzyme 
PABPC1 poly(A) binding protein, cytoplasmic 1 Cytoplasm translation 
regulator 
PAX4 paired box 4 Nucleus transcription 
regulator 
PGK1 phosphoglycerate kinase 1 Cytoplasm kinase 
PLA2G16 phospholipase A2, group XVI Nucleus other 
RGS2 regulator of G-protein signaling 2, 24kDa Nucleus other 
RPS29 ribosomal protein S29 Cytoplasm other 
SRXN1 sulfiredoxin 1 homolog (S. cerevisiae) Cytoplasm enzyme 
TMEM9B TMEM9 domain family, member B Plasma 
Membrane 
other 
TPI1 triosephosphate isomerase 1 Cytoplasm enzyme 
UPF3B UPF3 regulator of nonsense transcripts homolog 
B (yeast) 
Nucleus transporter 
 
